Childhood cancer: occurrence, treatment and risk of second primary malignancies
S Zahnreich, H Schmidberger - Cancers, 2021 - mdpi.com
Simple Summary Childhood cancers are mostly of unknown etiology and represent
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …
Current state of immunotherapy and mechanisms of immune evasion in ewing sarcoma and osteosarcoma
V Evdokimova, H Gassmann, L Radvanyi… - Cancers, 2022 - mdpi.com
Simple Summary Pediatric sarcomas, including Ewing sarcoma and osteosarcoma, were
first to be treated with an anticancer vaccine 100 years ago. This review moves on from a …
first to be treated with an anticancer vaccine 100 years ago. This review moves on from a …
High-dose treosulfan and melphalan as consolidation therapy versus standard therapy for high-risk (metastatic) Ewing sarcoma
R Koch, H Gelderblom, L Haveman… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Ewing 2008R3 was conducted in 12 countries and evaluated the effect of
treosulfan and melphalan high-dose chemotherapy (TreoMel-HDT) followed by reinfusion of …
treosulfan and melphalan high-dose chemotherapy (TreoMel-HDT) followed by reinfusion of …
Surgical treatment of bone sarcoma
F Bläsius, H Delbrück, F Hildebrand, UK Hofmann - Cancers, 2022 - mdpi.com
Simple Summary Even today, a malignant bone tumor is still a threatening condition for the
patient. Such tumors are difficult to treat and they require an interdisciplinary approach to …
patient. Such tumors are difficult to treat and they require an interdisciplinary approach to …
Evolution-informed strategies for combating drug resistance in cancer
The ever-changing nature of cancer poses the most difficult challenge oncologists face
today. Cancer's remarkable adaptability has inspired many to work toward understanding …
today. Cancer's remarkable adaptability has inspired many to work toward understanding …
The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review
AA Apfelbaum, ED Wrenn, ER Lawlor - Frontiers in oncology, 2022 - frontiersin.org
Accumulating evidence shows that despite clonal origins tumors eventually become
complex communities comprised of phenotypically distinct cell subpopulations. This …
complex communities comprised of phenotypically distinct cell subpopulations. This …
The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumors
The expression pattern, diagnostic value, and association of PD-L1, IFN-γ and TGF-β with
bone tumor type, severity, and relapse are determined in this study. 300 human samples …
bone tumor type, severity, and relapse are determined in this study. 300 human samples …
A bifunctional PARP-HDAC inhibitor with activity in ewing sarcoma
L Ramos, S Truong, B Zhai, J Joshi, F Ghaidi… - Clinical Cancer …, 2023 - AACR
Purpose: Histone deacetylase (HDAC) inhibition has been shown to induce pharmacologic
“BRCAness” in cancer cells with proficient DNA repair activity. This provides a rationale for …
“BRCAness” in cancer cells with proficient DNA repair activity. This provides a rationale for …
The oncolytic adenovirus XVir-N-31 joins forces with CDK4/6 inhibition augmenting innate and adaptive antitumor immunity in Ewing sarcoma
SJ Schober, C Schoening, J Eck, C Middendorf… - Clinical Cancer …, 2023 - AACR
Abstract Purpose: Ewing sarcoma (EwS) is a highly malignant pediatric tumor characterized
by a non-T-cell-inflamed immune-evasive phenotype. When relapsed or metastasized …
by a non-T-cell-inflamed immune-evasive phenotype. When relapsed or metastasized …
Current insights into the role of Fli-1 in hematopoiesis and malignant transformation
Y Ben-David, B Gajendran, KM Sample… - Cellular and Molecular …, 2022 - Springer
Fli-1, a member of the ETS family of transcription factors, was discovered in 1991 through
retroviral insertional mutagenesis as a driver of mouse erythroleukemias. In the past 30 …
retroviral insertional mutagenesis as a driver of mouse erythroleukemias. In the past 30 …